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1. Introduction
Oligosaccharides play a signiﬁcant role in the bioactivit
stability and functionality of serum proteins such as IgG.1 Eac
heavy chain of IgG has an N-glycan covalently linked at the highl
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sufﬁcient complexity and information content to serve as an excellent sourc
mammalian health. Since oligosaccharides play a signiﬁcant role in man
ry important to understand their structure. The glycosylation is cell type spe
le depending on the species producing the IgG. We evaluated the variation
man, bovine, ovine, equine, canine and feline IgG using three orthogonal gly
hydrophilic interaction liquid chromatography (HILIC)–UPLC, reversed phas
ctrophoresis with laser induced ﬂuorescence detection (CE-LIF). The separa
high resolution methods yielded different proﬁles due to diverse chemistrie
of structures obtained by CE-LIF and HILIC–UPLC were similar, whereas th
ﬁcult to compare as the structures were separated by classes of glycans (high
, bisected, fucosylated and bisected) resulting in the co-elution of man
various species were selected due to the complexity and variation in the
by highlighting the complementarity of these separation techniques.
 2014 Elsevier Ltd. All rights reserve
conserved Asn297 of the Fc region of the molecule; as well, 15–20
of normal polyclonal IgG molecules bear N-linked oligosaccharide
in the variable (V) regions of the light (L) and/or heavy (H) chains
Since glycosylation is species and cell type speciﬁc, IgGs produce
in different host mammals contain different oligosaccharide pa
terns. The glycan heterogeneity is a reﬂection upon the presenc
and lifetime of glycosyltransferases in the Golgi of the differen
species of mammals.3
Glycosylation of proteins is critical for biological function, an
consequently the analysis of this post translational modiﬁcatio
is ultimately important. With the advancement in novel technolo
gies, there are several methods available for the high-throughpu
separation and analysis of glycans. Rapid analysis methods are ben
eﬁcial for high throughput; however, results may vary dependin
on the separation technique selected. Current techniques for proﬁ
ing, characterization and analysis of glycans include hydrophil
liquid chromatography (HILIC),4–7 reverse phase chromatograph
(RP),8,9 capillary electrophoresis (CE),10–12 mass spectrometr
(MS),13–17 nuclear magnetic resonance (NMR) 18,19 amongst other
Since oligosaccharides have no appreciable photometric proper
ties, sensitive detection requires labelling the glycans with
able at ScienceDirect
te Research
elsevier .com/locate /carress. (2014), http://dx.doi.org/10.1016/j.carres.2014.01.018
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Plorescent tag. The HILIC separation of 2-aminobenzamide (2AB)
elled glycans, which is based on the hydrophilic interaction
tween the analyte and the stationary phase, is well characterized
d understood.7 The technology is robust, uses minimal glycopro-
in material and the technology has been optimized to enable
ort separation times.7,20,21 The ﬂuorescence detection is sensi-
e, allowing for detection of femtomolar concentrations.22 HILIC
paration is based on a polar stationary phase and a non-polar
obile phase.23 On the contrary, reverse phase separation is based
hydrophobicity and thus utilizes a non-polar stationary phase
d a polar mobile phase where glycans are eluted by increasing
ncentrations of organic solvent.
CE-LIF hasproven tobe a sensitive andhigh resolution separation
ethod that is already broadly utilized in the analysis of complex
rbohydrates, both by the biomedical as well as the biotechnology
dustries.24–26 CE separation is driven by an electric ﬁeld mediated
igrationand is thereforebasedoncharge tohydrodynamicvolume
tio. Highly charged species migrate ﬁrst. Additional structural
formation can be obtained when this electrophoretic separation
chnique is combined with exoglycosidase-array mediated
quencing.27 The selection of the label can have a profound effect
both the sensitivity and resolving power of the method.25 The
eal labelling agent for CE provides easy and fast glycan derivatiza-
n but also has high quantum yield, sufﬁcient charge properties
d an excitationwavelength that ﬁts for commercially available la-
rs. Themost commonly usedﬂuorophorewhichmeets these crite-
is 8-aminopyrene-1,3,6-trisulfonic acid (APTS).24,28
For each of the selected separation techniques peak retention/
igration times are directly correlated to a standard oligosaccha-
e ladder used to allow for initial structural assignment of the gly-
ns of interest. The choice of the ladder depends on the matrix by
ich the separation occurs. In case of HILIC the sugar ladder con-
ts of glucose units linked via an a1,6 linkage (dextran) with a 2AB
el at the reducing end, in RP it consists of L-arabinose units linked
an a1,5 linkage (arabinose ladder) also 2AB labelled, and in CE,
TS derivatized maltodextrin is used for structural assignment
lucose units linked via an a1,4 linkage).29 In either separation
echanism, each sugar chain oligomer has a distinct retention/
igration time. By correlation of the retention/migration time
d length of the sugar oligomer a calibration is generated to assign
(glucose units), AU (arabinose units) and GUCE (glucose units for
pillary electrophoresis) values to unknown oligosaccharides.
rthermore, with databases such as Glycobase,30,4 we are able to
sign the most probable structures to separated glycans. The
gestion of glycans from the non-reducing ends via use of exogly-
sidase enzymes allows for further conﬁrmation of the suggested
uctures and the determination of the sequence, anomericity and
kage of different sugars to the core structure.
In this paper we investigated three glycan separation methods
ing the N-glycans from the IgGs of human, bovine, ovine, equine,
nine and feline origin. Sampleswere treatedwith peptide-N-glyco-
ase-F (PNGase F), and the released oligosaccharide structureswere
alysed by three orthogonal glycan separation techniques: HILIC–
LC, RP–UPLC and CE-LIF. The methods took advantage of different
emistries, and thus should reﬂect the different attributes present in
e IgGglycans. The IgGs fromthesevarious specieswere selectedbe-
use of their complexity and variation in N-glycan composition to
hlight the complementarity of these separation techniques.
Materials and methods
. Materials
Human and ovine IgGs were obtained from Sigma-Aldrich (St.
uis, MO), while bovine (n = 12), equine (n = 10), canine (n = 8) and
ine (n = 8) serum samples were obtained from UCD Veterinaryease cite this article in press as: Adamczyk, B.; et al. Carbohydr. Res. (20iences. Samples were collected on the admission of the animal to
e veterinary clinic for biochemicalmeasurements, theywere stored
80 C and upon conﬁrmation of healthy status they were trans-
red for IgG puriﬁcation and glycan analysis. A representative pool
each species was prepared by pooling all individual subjects.
. Chemicals and reagents
Reagent water used throughout this study was obtained from a
illi-Q Gradient A10 Elix system (Millipore, Bedford, MA, USA) and
s 18.2 MO or greater with a total organic carbon (TOC) content
s than 5 parts per billion (ppb). Acetonitrile was Fisher Far UV
adient grade (Fisher Scientiﬁc, Waltham, MA). All other chemi-
ls used were purchased from Sigma–Aldrich (St.Louis, MO).
. IgG puriﬁcation
Protein G/A spin plates (Thermo Scientiﬁc) were pre-
nditioned with three washes of binding buffer (PBS) at room
mperature. Serum samples (50 lL) were diluted with 50 lL bind-
g buffer (PBS) and applied to the Protein G/A plate. The plate
sembly was shaken and incubated for 30 min for IgG binding.
ter incubation, the plate was washed ﬁve times with binding
ffer to remove non-speciﬁcally interacted proteins. IgG was
ted from the Protein G/A plate using 3  300 lL elution buffer
.5 M acetic acid, pH 2.5). Eluates were collected in a 96 deep well
ate and immediately neutralized to pH 7.0 with neutralization
ffer (1 M ammonium bicarbonate) to maintain the IgG stability.
The purity of the isolated IgGs was assessed using 10% reducing
S–PAGE in an Xcell SureLock Mini-Cell (Invitrogen, Carlsbad, CA)
cording to the manufacturer. Precision Plus Protein All Blue Stan-
rds (BioRad, Hercules, CA) was used as the molecular weight
arker. The gels were run at 50 mA for 45 min and stained with
l Code Blue staining reagent (Pierce, Rockford, IL). Separation
SDS–PAGE gel conﬁrmed presence of IgG and lack of any
-eluting proteins (data not shown). Therefore, the sample was
nﬁrmed to be pure and suitable for structural analysis of oligo-
ccharide structures.
. Enzymatic N-glycan release and labelling
Puriﬁed IgGs were reduced and alkylated before being set into
S–PAGE gel blocks, washed and digested with PNGaseF (Pro-
me, Hayward, CA, USA) for 16 hours as previously described by
yle et al.7
The eluted glycans were ﬂuorescently derivatized via reductive
ination with either 2-AB with sodium cyanoborohydride in 30%
v acetic acid in DMSO at 65 C for two hours for UPLC-ﬂuores-
nce studies (both HILIC and RP) or APTS in 15% v/v acetic acid
d 1 M sodium cyanoborohydride in tetrahydrofuran at 37 C
ernight for CE-LIF investigations. In both instances the labelling
action was quenched by the addition of water to yield a ﬁnal vol-
e of 100 lL. 900 lL of acetonitrile was then added to the reac-
n vial with subsequent excess ﬂuorophore removal by HILIC
ase pipette tips (PhyNexus, San Jose, CA, USA) using an adapta-
n of the method of Olajos et al.31 Exoglycosidase digestions were
rformed using a modiﬁed method of Royle et al.32 N-Glycan
menclature and symbolic representations used throughout are
previously described by Harvey et al.33
. UPLC-ﬂuorescence HILIC N-glycan proﬁling
2-AB derivatized N-glycans were separated by ultra-perfor-
ance liquid chromatography (UPLC) with ﬂuorescence detection
a Waters Acquity™ UPLC H-Class instrument consisting of a
ary solvent manager, sample manager and ﬂuorescence14), http://dx.doi.org/10.1016/j.carres.2014.01.018
detector under the control of Empower 3 chromatography work-
station software (Waters, Milford, MA, USA). The HILIC separations
were performed using Waters BEH Glycan column, 150  2.1 mm
i.d., 1.7 lm BEH particles, using a linear gradient of 70–53% aceto-
200 nitrile at 0.56 mL/min in 16.5 min. Solvent A was 50 mM formic
acid which was adjusted to pH 4.4 with ammonia solution and Sol-
vent B was acetonitrile. An injection volume of 20 lL sample pre-
pared in 80% v/v acetonitrile was used throughout. Samples were
maintained at 5 C prior to injection and the separation tempera-
ture was 40 C. The ﬂuorescence detection excitation/emission
wavelengths were kex = 330 nm and kem = 420 nm, respectively.
2.6. UPLC-ﬂuorescence RP N-glycan proﬁling
2-AB derivatized N-glycans were separated by reversed phase
using a Waters T3 C18 column, 150  2.1 mm i.d., 1.7 lm HSS par-
210 ticles. The buffers used were water with 0.1% formic acid (A) and
acetonitrile with 0.1% formic acid (B). The separation was carried
out with an initial isocratic separation of 97.5% A held for 5 min.
The % A was reduced to 95.5% over 1 min, and then separation
was carried out on a shallow gradient to 95% A over 15 min. The
sample was prepared in an injection volume of 20 lL in 100% v/v
water. The samples were maintained at 5 C prior to injection
and with a separation temperature of 65 C. The ﬂuorescence
detection excitation/emission wavelengths were kex = 330 nm and
kem = 420 nm, respectively. Retention times were converted into
220 arabinose unit (AU) values by time based standardization against
an arabinose ladder. The arabinose ladder was prepared by acidic
hydrolysis of linear arabinan (Megazyme, Bray, Ireland), spiked
with arabinose and the 2-mer to 9-mer arabinose sugars chains
(Megazyme, Bray, Ireland).
2.7. CE-LIF N-glycan proﬁling
Capillary electrophoresis separations of APTS labelled N-glycans
were performed on a Beckman PA800 Plus Pharmaceutical Analysis
System under the control of 32 Karat software, version 9.0
(Beckman Coulter, Brea, CA, USA) using a N-CHO neutral coated
230 capillary, 360 lmO.D., 50 lm I.D. Unless otherwise stated the total
capillary length was 60 cm with a 50 cm effective separation
length from the injection to the detector. The instrument was
equipped with a 3 mW 488 nm solid state laser and a 520 nm cut
off ﬁlter for laser induced ﬂuorescence detection. For all experi-
ments a commercially available carbohydrate separation buffer
was used (Beckman Coulter) at a separation temperature of 25 C
and using an applied potential of 30 kV, (500 Vcm1), reversed
polarity. Prior to use, the capillary was conditioned by subsequent
rinsing with water and carbohydrate separation buffer for 10 min
240 at 30 psi. In order to avoid any possible carryover, the capillary
was also rinsed with buffer for 5 min at 30 psi between injections.
To improve precision, two bracketing standards were used, APTS
-
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G
(human, equine, bovine, ovine) or Protein A (canine, feline) resin,
followed by removal of N-glycans by PNGaseF after immobilization
in gel plugs. Protein A binds to the Fc portion of the IgG molecule,
while Protein G preferentially binds to the Fc portion but also binds
the Fab region.34 The selection of Protein G or Protein A was based
260on the manufacturer guidelines indicating afﬁnity to different IgG
subclasses. The separation of the glycans by various methods
yielded different proﬁles; however, the % abundance of structures
obtained by CE-LIF and HILIC–UPLC were similar, whereas the
analysis by RP–UPLC was difﬁcult to compare as the structures
were separated by classes of glycans where many structures co-
eluted. As well, the abundance of sialylated or charged structures
in RP–UPLC was not determined due to the fast elution of these
structures with the mobile front. The separation time used for each
technique was based on optimized conditions to allow for high
270throughput separation of multiple samples with good resolution.
The Oxford notation system has been used to represent N-linked
glycan composition and structure (Fig. 2).33 We will discuss the
particular characteristics for each method in the subsequent
sections.
3.1.1. Analysis of IgG glycosylation by HILIC–UPLC
HILIC–UPLC separations were performed over 20 min, with the
neutral smaller structures eluting ﬁrst, and the large and charged
structures eluting later in the proﬁle (Fig. 3A). The human IgG gly-
can proﬁle yielded peaks eluting between GU 5 and 10 with major
280glycan structures eluting at GU 5.88; 6.70; 7.63, and 8.79 (Table 1).
From exoglycosidase digestion results (not shown) we identiﬁed
these glycans as FA2, FA2G1 and FA2G10, FA2G2 and FA2G2S1
structures. The largest structure possible on human IgG is
FA2BG2S2, with two N-acetylneuraminic acids (Neu5Ac).
The species speciﬁc variation of IgG glycans isolated from a pool
of serum from 6 different species is shown in Table 2 (HILIC–UPLC)
(CE is not shown as the abundance of each glycan is similar to the
results obtained by HILIC–UPLC). For simplicity, peaks that were
less than 0.5% relative abundance were not included in the table.
290The table shows that there are over 50 structures present in the
IgG glycans from different mammal species. In humans this is lim-
ited to 36 structures. The greater variation observed between non-
human species is due to the presence of N-glycolylneuraminic acid
(Neu5Gc) and larger proportions of bisected structures. As well, the
presence of structures containing terminal alpha-linked galactose
residues was detected. However, the individual structures contain-
ing alpha-linked galactose were less than 0.5% abundant of the
total glycan pool. Thus we will not focus on these structures here.
Consequently, the proﬁle of the mammal IgG glycans from serum
300yielded a proﬁle different than that of human (Fig. 3). The major
glycans from bovine IgG were fucosylated, with over 80% of
glycans consisting of a combination of FA2 (11.9%), FA2G1
(FA2[6]G1 and FA2[3]G1; 9.1% and 19.6%, respectively), and
FA2G2 (24.4%). There were roughly 20% bisected biantennary gly-
l
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ronic acid (2-AMAC GA) as the upper bracket. Samples were in
jected hydrodynamically at 1 psi for 5 s. Migration times wer
converted to relative migration times using the bracketing stan
dard boundaries. These normalized migration times were subse
quently converted to GU values using a ﬁfth order time base
standardization against a maltooligosaccharide ladder (Grain Pro
cessing Corporation, Muscatine, IA, USA).
3. Results
3.1. Analysis of IgG glycosylation using different techniques
The strategy for the analysis of N-glycans from IgG is shown i
Figure 1. The total IgG was puriﬁed from serum using ProteinPlease cite this article in press as: Adamczyk, B.; et al. Carbohydr. Recans also identiﬁed within the proﬁle. Most IgGs isolated from
the different mammal species showed some sialylation (N-acety
and N-glycolyl neuraminic acid); however, in most species thes
structures comprised less than 5% of the overall glycan pool, wit
the exception of FA2G2S1 (a2,6) in human (9.8%) and felin
(5.9%) and a disialylated A2G2S2 or FA2BG2Sg1 in the feline Ig
(6.8%). Some structures coeluted in the same peak, as their afﬁnit
to the column was similar and the elution time allocated was no
sufﬁcient to allow for complete separation.
Ovine IgG glycans contained a high percentage of bisected bian
tennary structures (>60%) of which >40% were fucosylated (Tabl
2). The majority of structures eluted between GU 5 and 8, and ove
85% consisted of neutral non-sialylated structures. The FA2 struc
ture dominated in both the canine and equine IgG glycan proﬁle
(over 50%). In feline, there was over 1% of A1 structure, compared
s. (2014), http://dx.doi.org/10.1016/j.carres.2014.01.018
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Plother species where this structure was present in negligible
ounts. Equine IgG contained more A2G0, FA2[6]G1 and
2[3]G1 glycans than canine IgG glycans. There were also higher
els of FA2G[6/3] 1 within the equine IgG proﬁles compared to
e canine proﬁles where the A2 structure was the second most
undant structure. An interesting glycoproﬁle was generated
m feline IgG, which had a highly distributed pattern. The great-
t amount of N-glycan present in feline proﬁle was A2 (25%) fol-
ed by FA2 (17%) while more complex structures were less
undant.
The structural assignments of IgG N-glycans from each mammal
re conﬁrmed by digestions using an exoglycosidase enzyme ar-
y. Arthrobacter ureafaciens sialidase—released a2-6, 3 and 8
ked non-reducing terminal sialic acids (ABS); bovine kidney
alp
te
fu
no
He
in
NA
IgG
of
10
m
fu
th
(w
ure 1. Overall strategy for analysis of IgG N-glycans using HILIC–UPLC, RP-UPLC and C
ples from different species; as an example, the proﬁles of bovine IgGs are presented he
ease cite this article in press as: Adamczyk, B.; et al. Carbohydr. Res. (20ha-fucosidase—released a1-2 and a1-6 linked non-reducing
rminal fucose residues more efﬁciently than a1-3 and 4 linked
cose (BKF); Bovine testes beta-galactosidase hydrolysed
n-reducing terminal b1-4 and b1-3 linked galactose (BTG);
xosaminidase cloned from Streptococcus pneumoniae expressed
Escherichia coli released GlcNAc residues but not a bisecting Glc-
340c linked to Man (GUH). An enzymatic digestion panel for bovine
N-glycans is shown in Figure 4A. The original proﬁle consisted
18 major peaks. After ABS digestion, FA2G2S2 structure with GU
, digests to an FA2G2 structure with a GU value of 7.63. The re-
oval of two sialic acids resulted in a shift of 2.37 GU value. The
cosidase digestions resolved much of the complexity, where
ere were four major peaks after the digestion step; A2, A2G1
ith galactose on the 3- or 6-arm) and A2G2. After galactosidase
E-LIF separation techniques. This strategy has been applied to analysis of IgG
re.
14), http://dx.doi.org/10.1016/j.carres.2014.01.018
digestion only two major peaks appeared identiﬁed as A2 and A2B.
Finally after hexosaminidase digestions two peaks (M3 and M3B)
350 remained.
3.1.2. IgG glycosylation analysis by RP–UPLC
The RP–UPLC glycan proﬁles are shown in Figure 3B and the
corresponding abundance of each speciﬁc group is shown in Table
3. The 2AB-labelled ladder used in RP separation is based on L-arab-
inose units linked via an a1,5 linkage (arabinose ladder), and struc-
tures are assigned an AU value. The groups are classiﬁed as follows:
(1) fucosylated, (2) fucosylated and bisected, (3) non-fucosylated
and (4) non-fucosylated and bisected. High mannose structures
were also separated from all other moieties; however, these were
360not prominent structures in mammal IgGs. Human, bovine, equine
and canine IgG glycans possess high percentage of fucosylated
non-bisected structures (>65%). Human IgG N-glycans contain
mostly fucosylated structures (FA2, FA2G1, FA2G2 and FA2G2S1)
as indicated by the major peaks eluted at 7.7 to 7.8 with a minor
percentage (about 10%) of fucosylated bisected structures eluting
at 11.5 AU. Bovine IgG was separated by RP–UPLC into 4 distinct
regions, where the non-fucosylated, non-bisected glycans were
eluted (between 3 and 6 AU), bisected non-fucosylated bisected
glycans were eluted between 6 and 7 AU, fucosylated glycans
370eluted between 7 and 8 AU, and ﬁnally fucosylated bisected gly-
cans eluted after 11 AU. Although the abundance of fucosylated
non-bisected structures was similar to that of humans, the amount
of non-bisected non-fucosylated structures was slightly higher in
bovine IgG. The separation of fucosylated, bisected glycans by
RP-UPLC gave a clear differentiation in proﬁles between bovine
and ovine IgG glycans that was not evident by the other techniques
examinated. Over 40% of fucosylated bisected glycans were present
in the ovine IgG glycan sample. The separation of the non-fucosy-
lated, nonbisected glycans (A2G0, A2G1, A2G2) was particularly
380apparent in ovine and feline IgG glycan proﬁles, as these structures
consisted of 12.9% and 28.9% of the overall proﬁle, respectively.
Both equine and canine IgG glycans yielded similar proﬁles as pre-
viously shown by HILIC–UPLC with the major peaks consisting of
fucosylated structures (FA2). The relative abundance of the non-
fucosylated and non-bisected, non-fucosylated bisected and
fucosylated bisected were similar for these species. Feline IgG gly-
cans had a higher percentage of non-fucosylated bisected struc-
tures than the other species investigated.
The RP–UPLC separation of exoglycosidase digested glycans did
390not yield speciﬁc digestion proﬁles as in the case of
Figure 3. N-glycosylation proﬁles of human, bovine, ovine, equine, canine and feline IgG using HILIC–UPLC (A), RP–UPLC, (B) and CE-LIF (C).
Figure 2. Structural symbols for the N-glycans, their linkages and abbreviations
used. Brieﬂy, all N-glycans have two core N-acetylglucosamines (GlcNAc) and a
trimannosyl core; F at the start of the abbreviation indicates a core fucose linked
a1-6 to the core GlcNAc; A[y]a, represents the number a of antenna (GlcNAc) on the
trimannosyl core linked to the a1-y mannose arm; B, bisecting GlcNAc linked b1-4
to b1-4 core mannose; Fb after Aa, represents the number b of fucose linked a1-3 to
antenna GlcNAc; Gc, represents the number c of galactose linked b1-4 on antenna;
S(z)d, represents number d of sialic acids (Neu5Ac) linked a2-z to the galactose,
Sg(z)d, represents number d of sialic acids (Neu5Gc) linked a2-z to the galactose.
The graphical symbols are used to represent the different sugar residues and
linkages between them. Symbols encode the following monosaccharide structures:
GlcNAc, ﬁlled square; sialic acid (Neu5Ac), ﬁlled star; sialic acid (Neu5Gc), ﬁlled star
with a white dot; galactose, open diamond; fucose, diamond with a dot inside,
mannose, open circle; beta linkage, solid line; alpha linkage, dotted line; unknown
beta linkage, solid wave; unknown alpha linkage, dotted wave.
B. Adamczyk et al. / Carbohydrate Research xxx (2014) xxx–xxx 5
CAR 6659 No. of Pages 13, Model 5G
12 February 2014
Please cite this article in press as: Adamczyk, B.; et al. Carbohydr. Res. (2014), http://dx.doi.org/10.1016/j.carres.2014.01.018
Table 1
Summary of N-glycan structural composition determined for human IgG
Structure Cartoon GU (HILIC–UPLC) AU (RP–UPLC) GUCE (CE-LIF)
1 F(6)A1 5.32 4.76
F(6)A1[6]: 6.65
F(6)A1[3]: 7.01
2 A2 5.41 4.07 6.67
3 A2B 5.78 6.35 7.20
4 F(6)A2 5.88 7.72 7.69
5 M5 5.92 2.71 6.75
6 F(6)A2B 6.24 11.22 8.20
7 A2[6]G1 6.25 4.07 7.74
8 A2[3]G1 6.38 4.07 8.04
9 A2B[6]G1 6.54 6.51 8.26
10 A2B[3]G1 6.71 6.51 8.55
11 F(6)A2[6]G1 6.70 7.80 8.75
12 F(6)A2[3]G1 6.84 7.80 9.08
13 F(6)A2B[6]G1 6.94 11.50 9.14
14 F(6)A2B[3]G1 7.07 11.50 9.55
15 A2G2 7.21 4.07 9.12
16 A2BG2 7.36 6.61 9.62
17 F(6)A2G2 7.63 7.80 10.13
.77
.77
.48
.62
.78
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Pl18 F(6)A2BG2 7
19 F(6)A1G1S1 7
20 A2[6]G1S1 7
21 A2[3]G1S1 7
22 A2B[6]G1S1 7ease cite this article in press as: Adamczyk, B.; et al. Carbohydr. Res. (2011.50 10.48
X
F(6)A1[6]G1S1: 5.08
F(6)A1[3]G1S1: 5.24
X 5.24
X 5.39
X 5.6514), http://dx.doi.org/10.1016/j.carres.2014.01.018
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Table 1 (continued)
Structure Cartoon GU (HILIC–UPLC) AU (RP–UPLC) GUCE (CE-LIF)
23 A2B[3]G1S1 7.93 X 5.99
24 M4A1G1S1 7.90 X X⁄
25 F(6)A2[6]G1S1 7.90 X 5.81
26 F(6)A2[3]G1S1 8.03 X 5.91
27 F(6)A2B[6]G1S1 8.13 X 6.00
28 A2G2S1 8.38 X 6.11
29 F(6)A2B[3]G1S1 8.38 X 6.13
30 A2BG2S1 8.61 X 6.37
31 F(6)A2G2S1 8.79 X 6.63
32 F(6)A2BG2S1 9.00 X 6.79
33 A2G2S2 9.58 X 4.54
34 A2BG2S2 9.74 X 4.70
35 F(6)A2G2S2 10.00 X 4.83
36 F(6)A2BG2S2 10.12 X 4.92
(AU es
mbo
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12 February 2014HILIC-separations. As the separation occurs by ‘classes’, the digestio
of speciﬁc terminal sugars yielded a change in the group type. More
over, the peaks did not shift with constant AU value, as the digestio
of sugars resulted in changes of hydrophobicity. Figure 4B shows th
separation of the exoglycosidase digestion products of bovine IgG
The ABS digestion resulted in a minor change in the earlier elutin
peaks; and an AU increase in the A2G2 peak to 4.07. A major chang
in the proﬁle occurred after BKF digestion,when the fucosylated pea
shifted from AU 7.8 to AU 4.7. The peak at AU 7.8 prior to BKF diges
tions contained two unresolved peaks (shoulder) indicating that th
peak contained more than one structure. Based on HILIC and CE-LI
analysis, this peak probably contained FA2, FA2G1 and FA2G2 struc
tures. Therewerealsochanges in theshifts of someminorpeaks in th
AU range of 6.25–6.5 corresponding to bisected nonfucosylate
All N-glycans are reported with corresponding glucose units (GU), arabinose units
from human IgG. Structures are given in the Oxford notation32 and structural syPlease cite this article in press as: Adamczyk, B.; et al. Carbohydr. Restructures (A2BG0, A2BG1 andA2BG2) after galactosidase digestion
After the application of the full digestion panel, only the A2 structur
remained (AU = 3.0).
3.1.3. Analysis of IgG glycosylation by CE-LIF
CE traces of the IgG glycans from different species are shown i
Figure 3C. Full migration required over 30 min; however, th
majority of glycans migrated through the detection window
between 10 and 18 min. The separation yielded very narrow
individual peaks, indicating complete resolution of the isomer
The separation trace was similar to the HILIC separation proﬁle
however, some peaks were more prominent in the HILIC trace
compared to the CE traces. In the HILIC traces some of the large
peaks were composed of more than one structures, as in the cas
) and glucose units (capillary electrophoresis) (GUCE) values for IgG N-glycan structur
ls for the N-glycans, their linkages and abbreviations are presented in Figure 2.s. (2014), http://dx.doi.org/10.1016/j.carres.2014.01.018
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Table 2
Relative abundances of the IgG glycan structures from the six mammalian species, as determined by HILIC–UPLCb analysis
GU Abundance (% area)
Human Bovine Ovine Equine Canine Feline
A1 4.8 1.2
A2 5.4 0.7 1.7 2.6 2.8 12.5 23.3
A2B 5.8 1.0
F(6)A2 5.9 20.6 11.9 5.5 50.8 56.2 16.3
F(6)A2B 6.2 5.3 4.8 9.5 3.3 6.1
A2[6]G1
F(6)A2B/A2[3]G1 6.4 2.5 3.2 0.7 1.2 5.1
A2B[6]G1 6.5 3.0
A2B[3]G1
F(6)A2[6]G1 6.6 18.1 9.1 4.7 7.6 4.2 5.7
F(6)A2[3]G1 6.8 9.2 19.6 5.5 11.1 4.1 4.7
F(6)A2B[6]G1 6.9 4.8 3.8 14.9
F(6)A2B[3]G1 7.0 0.6 1.5 2.4 0.7 2.0 0.9
F(6)A2B[3]G1/A2G2 7.1 0.8 3.4 4.5 2.8
A2BG2 7.3 3.1
F(6)A2G2 7.5 13.7 24.4 13.1 5.5 0.8 5.4
F(6)A2BG2 7.6 1.6 2.8 15.8 1.3 0.5
F(6)A1G1S1
A2[6]G1S1
A2[3]G1S1
A2B[6]G1S1
A2B[3]G1S1
F(6)A2[3]G1S1 7.9 2.9 0.9 1.2 1.1 1.6
F(6)A2B[6]G1S1
A2[6]G2Sg1a
A2[3]G1Sg1a
A2G2S1 8.0 1.6 2.5 0.9 3.3
F(6)A2B[3]G1S1
F(6)A2G2S1(a2,3)
A2G2Sg1a
F(6)A2G2Sg1 (a2,3)a 8.2 1.4
A2BG2S1 8.6
F(6)A2G2S1 (a2,6) 8.8 9.8 2.9
F(6)A2BG2S1 9.0 2.8
F(6)A2G2Sg1a 9.1 4.3
A2G2S2(a2,6/a2,6) 9.6 1.9 0.8
F(6)A2BG2Sg1a
A2BG2S2 9.7
F(6)A2G2S2 10.0 2.6
A2G2S1Sg1a 10.1 3.2 2.7
A2G2Sg2a
F(6)A2G2Sg2 (a2,3/a2,3)a
F(6)A2BG2Sg2 (a2,3/a2,3)a
F(6)A2BG2S2
A2G2Sg2 (a2,6/a2,6)a 10.3 1.5
a ns.
b wev
con
Q2
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Plthe peak GU = 6.25 (A2[6]G1 and FA2B) in the human IgG, how-
er, in the CE electropherogram these two structures were well
solved having GUCE of 8.20 and 7.74, respectively.
The CE-LIF exoglycosidase digestion patterns (Fig. 4C) were sim-
r to HILIC–UPLC digestions. Since the peaks eluting between 4
d 7 GUCE shifted to corresponding peaks of A2, FA2, A2G1,
2G1, A2G2 and FA2G2 after ABS digestions, these peaks were
entiﬁed as sialylated. A digestion proﬁle panel shows similar pat-
rns to the HILIC–UPLC chromatograms albeit their digested prod-
t of an enzymatic reaction shifted to smaller GU values. Apart
m the sialic acid containing structures, the digestions of the
her terminal sugars yielded predictable GU shifts.
Discussion
In this paper we compared three separation methods to inves-
F(6)A2G2S1Sg1 (a2,6/a2,6)a
F(6)A2G2Sg2 (a2,3/a2,6)a
F(6)A2BG2Sg2 (a2,3/a2,6)a
F(6)A2BG2Sg2 (a2,6/a2,6)a 10.8 0.8
N-Glycolyl neuraminic acid containing structures—not present in human IgG glyca
Relative abundances as determined by CE were similar to that obtained in HILIC; Ho
taining structures.ate the overall IgG glycosylation proﬁle of various mammalian lab
ease cite this article in press as: Adamczyk, B.; et al. Carbohydr. Res. (20ecies (human, bovine, ovine, equine, canine and feline). The com-
rison of the separation methods included HILIC–UPLC, RP–UPLC
d CE-LIF. The methods utilized different separation principles,
d thus enabled mostly orthogonal analysis of the different sugar
uctures.
Each method has different requirements in respect to sample
eparation, necessary equipment and separation time but offers
asi orthogonal information about the glycans present. All
pects discussed below should be taken into account when select-
g the technique of choice. Comparison of the data obtained for
man IgG by each method is shown in Table 1. The percentage
undance of N-glycan structures calculated from each method is
ilar, suggesting that the separation and detection of glycans
each method do not have structural selectivity. This is especially
portant in the case of APTS labelling in CE-LIF glycan separation
chnique, as published data have indicated the importance of
1.8 3.1 0.9
1.7
2.5 2.2 2.6 5.9
1.1 1.1 0.7
2.5 3.0 1.7 2.8
1.1 2.0 3.4 6.8
0.6 1.0
1.7 2.1 2.4
0.6 1.4 1.6
0.8 0.6 1.0
0.6 1.1 0.9
er, there was some ambiguity between N-acetyl and N-glycolyl neuraminic acidelling under optimized conditions so that sialylation or other
14), http://dx.doi.org/10.1016/j.carres.2014.01.018
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Figure 4. Exoglycosidase panel digestions of bovine IgG glycans separated by HILIC–UPLC (A), RP–UPLC (B) and CE-LIF (C). The exoglycosidase panel consisted of Arthrobacter
ureafaciens sialidase (ABS), Bovine kidney alpha-fucosidase (BKF), Bovine testes beta-galactosidase (BTG) and hexosaminidase (GUH), with sequential additions.
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report on the separation of IgG glycans, this is less crucial, as sialy
lation is quite low, representing only about up to 5% of the tota
glycan pool from each species. The detection limit of APTS-labelle
glycans by CE-LIF is estimated to be 0.4 nM using a 3 mW 488 nm
argon-ion laser,36 which is slightly less sensitive than HILIC–UPLC
however, the injection volume of the latter is on average 3 order
of magnitude higher than in CE. CE-LIF allows for the separatio
of all IgG glycans in 8 min based on the conditions applied in th
paper with the overall separation time just over 20 min. The us
of CE-LIF as a method of glycan separation of monoclonal antibod
ies has been thoroughly discussed previously and the separation o
glycans by this method for the elucidation of structural isomer
has proven effective.12,31,37 However, as these CE-LIF studies i
the literature have been compared to separation of glycans by H
LIC–UPLC, the separation of structural isomers will not be dis
cussed further here. Besides the CE system used in this stud
other commercially available general purpose CE units can als
be used in a similar manner.38 Special capillary based system
such as DNA sequencers, require medium to high viscosity ge
to run the instruments, thus only allow electrokinetic injec
tion.39,40 Unfortunately, this causes sample introduction bias an
concomitantly alters the resulting proﬁle.
Table 3
Relative abundances of IgG glycan classes from the six mammalian species,
determined by RP-UPLC analysis
% Abundance
Human Bovine Ovine Equine Canine Feline
‘Classes’ of glycans
Fucosylated &
non-bisected
68.3 68.6 14.5 75.3 74.3 21.1
Fucosylated &
bisected
10.4 12.0 46.3 3.2 1.1 6.3
Non-fucosylated &
non-bisected
5.5 8.7 12.9 8.2 7.0 28.9
Non-fucosylated &
bisected
15.8 10.7 26.3 13.3 17.6 43.7Please cite this article in press as: Adamczyk, B.; et al. Carbohydr. ReThe separation method for glycan analysis by RP–UPLC an
HILIC–UPLC, used in this paper, occurred over 15 and 18 min
respectively. The separation of the glycans in RP–LC separatio
mode occurs in well-deﬁned zones such as high-mannose struc
tures eluting ﬁrst, followed by biantennary complex structure
and ﬁnally the fucosylated complex structures. RP separatio
groups are based on the hydrophobicity; thus major difference
in glycan structures can be easily visualized, that is the large pro
portion of bisected glycans in ovine. In contrast to HILIC separation
RP data analysis has greater difﬁculty in assigning individual gly
can structures. The shift in AU values of digested glycan structure
run on RP–UPLC is not predictable based on sequential removal o
terminal sugar residues. Since the sugar structures are separate
based on the hydrophobicity of the glycan and the ﬂuorescen
tag,41 the removal of terminal sugars may have an unpredictabl
inﬂuence on the shift of glycans after digestion. With the HILI
method one can expect reproducible shifts in the range of 0.4 t
1.15 (and 0.15 to 0.2 for bisecting GlcNAcs), for exoglycosidase d
gested glycans depending on the sugars removed. In case of com
bined sialidase (ABS) and fucosidase (BKF) digestions fo
example, the peak at 7.8 shifted to 4.07 AU as shown in Figure 4B
Sialylated glycans could not be identiﬁed by RP–UPLC analyse
as these structures are highly hydrophilic and elute from the co
umn with the void. This method can therefore only be used fo
the analysis of non-charged structures. RP-UPLC glycan separatio
could be applied in the biotechnology industry for the analysis o
N-glycans from CHO produced monoclonal antibodies where sialy
lation is generally less than 2%. RP–UPLC may be highly applicabl
for samples containing structures with bisecting GlcNAc or hig
mannose structures as glycans containing these features elute i
separate groups. It must be noted however that many structure
have a tendency to co-elute, such as the fucosylated A2, fucosyla
ed A2G1 and fucosylated A2G2 with this method. In genera
RP–UPLC of glycans is not as efﬁcient as HILIC–UPLC or CE-LI
and RP–UPLC data analysis has greater difﬁculty in assigning ind
vidual glycan structures, but it could be used as a complementar
tool for example, in 2D separations to resolve structures that pos
sibly co-elute in HILIC.9s. (2014), http://dx.doi.org/10.1016/j.carres.2014.01.018
The glycan peaks in RP mode generally have shoulders, and are
not resolved completely. Although this can be an issue with all the
investigated methods, this is particularly prevalent in RP, but can
be optimized by using different packing materials or varying elu-
tion conditions (i.e., gradients). However, as the buffer gradient
in RP-UPLC separations is quite shallow, modiﬁcation is challeng-
ing. Alternate packing materials are under current investigation
and need to be tested for increased resolution of complex glycans.
Extensive research efforts have been put into the understanding of
520 the fundamental retention behaviour of analytes when separated
by columns comprised of various packing materials; in particular
the separation by monolithic silica,42,43 or silanol silica.44 For the
analysis of larger complex glycans RP separation would be most
efﬁcient especially when coupled with mass spectrometry.9,41,45,46
Such coupling however, increases analysis times and requires fur-
ther expertise.
Table 1 shows the different glucose units using a dextran ladder
(GU), arabinose ladder (AU) and maltooligosaccharide ladder
(GUCE) values of various structures identiﬁed from IgG glycans in
530 human. It is important to point out that the values are different be-
tween each method; due to the difference in the separation princi-
ples. Although the CE and HILIC methods utilize GU values, the
ladders used for unit identiﬁcation are composed of a differently
linked glucose polymers (a1-4 and a1-6 linked glucose polymers,
respectively). CE separation is based on the charge to hydrody-
namic volume ratio of the analyte molecules. Since most carbohy-
drates are not charged labelling of the glycans with a charged
ﬂuorophore or chromophore is necessary for their electric ﬁeld
mediated separation. The development of sugar unit databases
540 has been the focus of several leading laboratories over the past
years. Glycobase 3.2 comprises the data of over 600 N-glycan
structures separated by HILIC–HPLC and HILIC–UPLC (http://
glycobase.nibrt.ie). The developments of RP- and CE-LIF databases
are ongoing. The differences between the three methods investi-
gated in this study are outlined in Table 4.
HILIC or CE are generally the ﬁrst methods of choice, as plenty
of information is available for data interpretation from the respec-
tive databases. The separation of glycans by HILIC requires an UPLC
or HPLC. The latter is often available in most laboratories thus en-
550 abling relatively affordable analysis. On UPLC columns analytical
separations for glycan samples are now reduced to only 30 minutes
or less, and the techniques are continually improving to accommo-
date high throughput glycan analysis needs. Sample preparation
protocols were labour-intensive but with the recently developed
robotic platforms for IgG N-glycan analysis the throughput capa-
bilities are much greater 47–49 and based on 96 or 384 well plates.
General interest in glycan analysis continues to grow as more life
science researchers realize its importance in many biological pro-
cesses. With growing interest and developed technologies, glycom-
560ic analysis should becomemore common in academic, industrial as
well as healthcare centres.
The HILIC–UPLC- and CE-LIF based separations also enable
glycoproﬁling with position/linkage assignments when used in
combination with exoglycosidase digestion arrays. For each sepa-
ration technique the enzyme array yields different traces; in the
case of HILIC and RP UPLC, due to the interaction of the glycans
with the stationary phase, and in the case of CE-LIF, the change
in the overall charge to mass ratio imparted upon the glycans.
While exoglycosidase digestion results are predictable in HILIC-
570and CE-LIF; RP-separation is unable to deliver linkage information
due to the lack of resolving power. Another drawback of RP is the
presence of non-glycan compounds (contaminant) peaks interfer-
ing with glycans of AU values from 6 to 7.5. These contaminants
may originate from the glycoprotein itself during the release pro-
ce
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Table 4
Advantages and disadvantages of methods presented in this article
Method HILIC–UPLC RP–UPLC CE-LIF
Information
Order of erutins structures From simple to more complex Based on structural features and
hydrophobicity
From simple to more complex, with
sialylated ﬁrst
Comparison to standard Yes Yes Yes
Oligosaccharide ladder Dextran Arabinose Maltodextrin
Availability of database Yes No* No*
Number of structures in the
database
600 — —
Obtained information Glycan proﬁling; structure; linkage
assignments
Glycan proﬁling; structure Glycan proﬁling; structure; linkage
assignments
Exoglycosidase digestions Predictable Not-predictable Predictable
Technical aspects
Relative quantiﬁcation Yes Yes Yes
Sample volume 10–25 lL 25 lL <1 lL
Resolution High Medium High
Mobile Phase 50 mM Ammonium Formate/Acetonitrile Ammonium Formate/1% Formic acid Proprietary Carbohydrate buffer
Stationery Phase BEH column C18 column CHO coated capillary
Operational constraints
Labelling 2-AB 2-AB APTS
Separation time 10–30 min 10–30 min 20 min
Data analysis Medium Medium Medium
User expertise 3–6 months 3–6 months 3–6 months
High-throughput capability Yes Yes Yes
* The developments of RP- and CE-LIF databases are ongoing.
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Please cite this article in press as: Adamczyk, B.; et al. Carbohydr. Res. (20ss. In addition, charged glycans elute with the solvent front,
d thus could not be identiﬁed. While HILIC- and CE-LIF analysis
able relative and absolute quantiﬁcation of individual structures,
- separation enables relative quantiﬁcation of groups of glycans,
e to structural co-elution. HILIC– and RP–UPLC analysis of gly-
ns requires a label with a minor function to mediate HILIC–UPLC
paration, and a major function in RP separation.
Other methods of analyses, such as mass spectrometric meth-
s using fragmentation, can be used to elucidate the glycosylation
fferences between the IgG from different species. Sequence infor-
ation can be generated by fragmentation, but linkage position
pe and position is less straightforward. The use of exoglycosidase
zymesmay be possible; however, due to the introduction of salts
the reaction buffer samples require extensive sample clean up or
ization efﬁciency maybe compromised. For linkage analysis, for
stance using permethylation or exoglycosidase digestions, more14), http://dx.doi.org/10.1016/j.carres.2014.01.018
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Structures with >5% abundance in mammalian IgGs
Nomenclature Structure % Abundance
Human
F(6)A2 20.6
A2[6]G1 or F(6)A2B 5.3
F(6)A2[6]G1 18.1
F(6)A2[3]G1 9.2
F(6)A2G2 13.7
F(6)A2G2S(6)1 9.8
Bovine
F(6)A2 11.9
F(6)A2[6]G1 9.1
F(6)A2[3]G1 19.6
F(6)A2G2 24.4
Ovine
F(6)A2 5.5
F(6)A2B 9.5
F(6)A2[3]G1 5.5
F(6)A2B[6]G1 14.9
F(6)A2G2 13.1F(6)A2BG2 15.8
Equine
F(6)A2 50.8
F(6)A2[6]G1 7.6
Please cite this article in press as: Adamczyk, B.; et al. Carbohydr. Reglycan material would be necessary, due to sample preparatio
losses by either technique.
Our analysis of the IgG glycans from various mammalian spe
cies highlights the beneﬁts of using various methods for analys
and indicated high structural variation in the mammalian IgG gly
cans, while being consistent with previously published data.50 Raj
Table 5 (continued)
Nomenclature Structure % Abundance
F(6)A2[3]G1 11.1
F(6)A2G2 5.5
Canine
A2 12.5
F(6)A2 56.2
Feline
A2 23.3
F(6)A2 16.3
F(6)A2B/A2[6]G1 6.1
F(6)A2B/A2[3]G1 5.1
F(6)A2[6]G1 5.7
F(6)A2G2 5.4
F(6)A2G2S1 5.9
A2G2S(6,6)2/
F(6)A2G2Sg(3)1
6.8and colleagues reported on the glycosylation differences from 13
different species using CE-LIF and MALDI-TOF-MS analyses.50 Their
results indicated species-speciﬁc variation in core fucosylation,
600terminal galactosylation and bisecting GlcNAc residues. Another
study compared the IgG glycosylation from 11 species, porcine,
equine, bovine, goat, ovine, canine, rabbit, guinea-pig and rat, by
microsequencing and lectin afﬁnity chromatography.51 The IgG
glycans identiﬁed by Hamako et al.51 consisted of biantennary
complex-type oligosaccharides containing 0–2 sialic acid resi-
due(s), where more than 70% of the oligosaccharides were neutral
s. (2014), http://dx.doi.org/10.1016/j.carres.2014.01.018
and fucosylated trimannosyl core structures. The bisecting residue
was absent in equine IgGs. In agreement with our results, large
quantities of agalactosylated oligosaccharides were identiﬁed in
610 equine and canine IgGs.
The techniques discussed in this paper resolved glycan struc-
tures from the various species. Using these orthogonal methods
for the analysis of N-glycans from the IgGs from different species,
information regarding the glycan differences in IgGs can be gath-
ered. The most abundant structures from studied species are sum-
marized in Table 5. The HILIC–UPLC is reliable technique that
effectively separates and quantitates structures on the basis of
both sequence and linkages. The isolation of different classes of
N-glycans (highly mannosylated, fucosylated, bisected, fucosylated
620 and bisected) by RP–UPLC offers the separation of IgG N-glycans by
group classes. And ﬁnally separation by CE-LIF offers separation by
the relationship of the charge imposed by the electric ﬁeld to
hydrodynamic volume. In conclusion, these fast and effective sep-
aration techniques can be used along with other analytical meth-
odologies to allow for full structural characterization.
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